Precision Medicine for All: Strategies for Meaningful and...

In spite of the clinical strides with precision medicine for non-small cell lung cancer (NSCLC), many patients, especially African American and Hispanic patients, face disparities with access to these advances. In this program, expert faculty focus on the latest data on NSCLC health disparities.

Category:
Description:

Despite the advances in precision medicine for non-small cell lung cancer (NSCLC), a significant proportion of patients, particularly African American and Hispanic patients, face inequities with access to these health breakthroughs. In this activity, expert faculty focus on the latest evidence with NSCLC disparities of care and how to best overcome these barriers. The activity also reviews how to assess opportunities to increase referral of minority patients to clinical trials and how to optimize overall care coordination among minority patients with NSCLC.

Claim credit: https://www.achlcme.org/reduce-health-disparities-nsclc-onctube